• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管磁共振在评估 COVID-19 心脏受累中的应用:心血管磁共振学会的建议。

Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.

机构信息

University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Oxford British Heart Foundation Centre of Research Excellence, The National Institute for Health Research Oxford Biomedical Research Centre at the Oxford University Hospitals NHS Foundation Trust, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Department of Biomedical Imaging Science, University of Leeds, Leeds, UK.

出版信息

J Cardiovasc Magn Reson. 2023 Mar 27;25(1):21. doi: 10.1186/s12968-023-00933-0.

DOI:10.1186/s12968-023-00933-0
PMID:36973744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10041524/
Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.

摘要

新型冠状病毒病 2019(COVID-19)是一种正在持续的全球大流行疾病,迄今为止已在全球范围内影响了近 6 亿人。虽然 COVID-19 主要是一种呼吸道疾病,但也已知会发生心脏损伤。心血管磁共振(CMR)成像具有独特的能力,可以在体内对心肌组织特性进行特征描述,从而深入了解心脏损伤的模式和程度。在先前住院的 COVID-19 感染患者中,CMR 识别的心肌受累的报告患病率范围为 26%至 60%。心肌受累的报告患病率的差异可能是由于患者人群的不同(例如疾病严重程度的差异)以及急性感染和 CMR 评估之间的间隔时间不同。在跨学科的 CMR 异常获取、分析、解释和报告中采用标准化方法,可能会提高研究之间的一致性。该共识文件由心血管磁共振学会(SCMR)提供了关于 CMR 成像和报告指标的建议,旨在改进 COVID-19 感染患者进行 CMR 时的标准化和统一数据获取和分析方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/5bd5b0f7421b/12968_2023_933_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/5da9d2558036/12968_2023_933_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/8215a0af3382/12968_2023_933_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/7e1b6a95b832/12968_2023_933_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/5bd5b0f7421b/12968_2023_933_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/5da9d2558036/12968_2023_933_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/8215a0af3382/12968_2023_933_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/7e1b6a95b832/12968_2023_933_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a33/10041810/5bd5b0f7421b/12968_2023_933_Fig4_HTML.jpg

相似文献

1
Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.心血管磁共振在评估 COVID-19 心脏受累中的应用:心血管磁共振学会的建议。
J Cardiovasc Magn Reson. 2023 Mar 27;25(1):21. doi: 10.1186/s12968-023-00933-0.
2
Utilization of cardiovascular magnetic resonance (CMR) imaging for resumption of athletic activities following COVID-19 infection: an expert consensus document on behalf of the American Heart Association Council on Cardiovascular Radiology and Intervention (CVRI) Leadership and endorsed by the Society for Cardiovascular Magnetic Resonance (SCMR).COVID-19 感染后恢复运动活动的心血管磁共振(CMR)成像的利用:代表美国心脏协会心血管放射学和介入委员会(CVRI)领导层的专家共识文件,并得到心血管磁共振学会(SCMR)的认可。
J Cardiovasc Magn Reson. 2022 Dec 21;24(1):73. doi: 10.1186/s12968-022-00907-8.
3
MRI of cardiac involvement in COVID-19.COVID-19 患者心脏病变的 MRI 表现。
Br J Radiol. 2024 Aug 1;97(1160):1367-1377. doi: 10.1093/bjr/tqae086.
4
Cardiovascular Magnetic Resonance for Patients With COVID-19.COVID-19 患者的心血管磁共振成像
JACC Cardiovasc Imaging. 2022 Apr;15(4):685-699. doi: 10.1016/j.jcmg.2021.08.021. Epub 2021 Oct 13.
5
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry.基于心血管磁共振的多中心国际研究——CARDOVID 登记研究:COVID 后多系统炎症综合征患儿的心肌受累。
J Cardiovasc Magn Reson. 2021 Dec 30;23(1):140. doi: 10.1186/s12968-021-00841-1.
6
T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study.T2 映射增加是活动性 COVID-19 中心肌受累的主要影像学生物标志物:一项心血管磁共振研究。
J Cardiovasc Magn Reson. 2021 Jun 10;23(1):68. doi: 10.1186/s12968-021-00764-x.
7
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis.急性和亚急性 COVID-19 疑似心肌炎患者的心脏磁共振成像表现。
J Clin Ultrasound. 2023 May;51(4):613-621. doi: 10.1002/jcu.23416. Epub 2022 Dec 21.
8
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.新型冠状病毒 2 型在年轻竞技运动员心脏中的作用。
Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17.
9
Cardiac Magnetic Resonance Imaging in Coronavirus Disease 2019 (COVID-19): A Systematic Review of Cardiac Magnetic Resonance Imaging Findings in 199 Patients.新冠肺炎(COVID-19)的心脏磁共振成像:199 例患者的心脏磁共振成像结果的系统评价。
J Thorac Imaging. 2021 Mar 1;36(2):73-83. doi: 10.1097/RTI.0000000000000574.
10
Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case-control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC).症状性 SARS-CoV-2 感染后士兵的心血管磁共振评估:SARS-CoV-2 感染后心血管急性后遗症(CV PASC)的病例对照研究。
J Cardiovasc Magn Reson. 2021 Oct 7;23(1):106. doi: 10.1186/s12968-021-00798-1.

引用本文的文献

1
Assessment of the myocardial effects of Bradykinin inhibitors by cardiac magnetic resonance (CMR) in discharged COVID-19 patients.在出院的COVID-19患者中,通过心脏磁共振成像(CMR)评估缓激肽抑制剂对心肌的影响。
Sci Rep. 2025 Aug 11;15(1):29340. doi: 10.1038/s41598-025-15489-5.
2
Improved diagnosis of COVID-19 vaccine-associated myocarditis with cardiac scarring identified by cardiac magnetic resonance imaging.通过心脏磁共振成像识别心脏瘢痕来改善对新冠疫苗相关心肌炎的诊断。
Open Heart. 2025 Jul 18;12(2):e003333. doi: 10.1136/openhrt-2025-003333.
3
Abnormal coronary vascular response in patients with long COVID syndrome - a case-control study using oxygenation-sensitive cardiovascular magnetic resonance.

本文引用的文献

1
Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.BNT162b2 和 mRNA-1273 冠状病毒疫苗第二剂后心肌炎/心包炎的比较风险。
J Am Coll Cardiol. 2022 Nov 15;80(20):1900-1908. doi: 10.1016/j.jacc.2022.08.799.
2
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险:按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
3
Patients With Myocarditis Associated With COVID-19 Vaccination.
长新冠综合征患者的异常冠状动脉血管反应——一项使用氧敏心血管磁共振的病例对照研究
J Cardiovasc Magn Reson. 2025;27(1):101890. doi: 10.1016/j.jocmr.2025.101890. Epub 2025 Apr 2.
4
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素,以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
5
Can FDG PET Serve as a Clinically Relevant Tool for Detecting Active Non-sarcoidotic Myocarditis?氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)能否作为检测活动性非结节病性心肌炎的临床相关工具?
Nucl Med Mol Imaging. 2024 Dec;58(7):406-417. doi: 10.1007/s13139-023-00827-0. Epub 2023 Oct 31.
6
Echocardiographic Assessment of Cardiac Function and Reserve Under Exercise in Post-COVID-19 Children: A Prospective Cross-sectional Study.新冠疫情后儿童运动状态下心脏功能及储备的超声心动图评估:一项前瞻性横断面研究
CJC Pediatr Congenit Heart Dis. 2024 Aug 9;3(5):203-213. doi: 10.1016/j.cjcpc.2024.08.001. eCollection 2024 Oct.
7
Cardiac MRI Pectoralis Muscle Thickness as a Measure of Sarcopenia: Prognostic Significance, Interreader Agreement, and Physiologic Correlation.心脏 MRI 胸大肌厚度作为肌少症的测量指标:预后意义、观察者间一致性和生理相关性。
Radiol Cardiothorac Imaging. 2024 Dec;6(6):e240147. doi: 10.1148/ryct.240147.
8
Impactful Cardiac CT and MRI Articles from 2023.2023 年有影响力的心脏 CT 和 MRI 文章。
Radiol Cardiothorac Imaging. 2024 Oct;6(5):e240142. doi: 10.1148/ryct.240142.
9
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA: longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study.美国年轻人中与新冠疫苗相关的心肌炎的心脏表现及预后:新冠疫苗接种后心肌炎(MACiV)多中心研究的纵向结果
EClinicalMedicine. 2024 Sep 6;76:102809. doi: 10.1016/j.eclinm.2024.102809. eCollection 2024 Oct.
10
The Correlation between Cardiac Magnetic Resonance Findings and Post-COVID-19: The Impact of Myocardial Injury on Quality of Life.心脏磁共振成像结果与新冠后情况的相关性:心肌损伤对生活质量的影响。
Diagnostics (Basel). 2024 Sep 2;14(17):1937. doi: 10.3390/diagnostics14171937.
与新冠疫苗接种相关的心肌炎患者。
J Am Coll Cardiol. 2022 Apr 5;79(13):1317-1319. doi: 10.1016/j.jacc.2022.02.004.
4
Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.以色列新兵接种第三剂 BNT162b2 疫苗后发生心肌炎。
JAMA. 2022 Apr 26;327(16):1611-1612. doi: 10.1001/jama.2022.4425.
5
Long-term cardiovascular outcomes of COVID-19.COVID-19 长期心血管后果。
Nat Med. 2022 Mar;28(3):583-590. doi: 10.1038/s41591-022-01689-3. Epub 2022 Feb 7.
6
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.美国 2020 年 12 月至 2021 年 8 月报告的基于 mRNA 的 COVID-19 疫苗接种后心肌炎病例。
JAMA. 2022 Jan 25;327(4):331-340. doi: 10.1001/jama.2021.24110.
7
Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.近期从 COVID-19 中康复患者的心脏氟脱氧葡萄糖正电子发射断层扫描/磁共振成像心肌损伤的联合评估。
JAMA Cardiol. 2022 Mar 1;7(3):298-308. doi: 10.1001/jamacardio.2021.5505.
8
A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection.2019冠状病毒病感染中左心室血栓的表现及转归综述
J Clin Transl Res. 2021 Nov 6;7(6):797-808. eCollection 2021 Dec 28.
9
Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry.基于心血管磁共振的多中心国际研究——CARDOVID 登记研究:COVID 后多系统炎症综合征患儿的心肌受累。
J Cardiovasc Magn Reson. 2021 Dec 30;23(1):140. doi: 10.1186/s12968-021-00841-1.
10
Myocardial Perfusion Imaging After Severe COVID-19 Infection Demonstrates Regional Ischemia Rather Than Global Blood Flow Reduction.重症新型冠状病毒肺炎感染后的心肌灌注成像显示为局部缺血而非整体血流减少。
Front Cardiovasc Med. 2021 Dec 7;8:764599. doi: 10.3389/fcvm.2021.764599. eCollection 2021.